GIOTRIF rPMS in Korean Patients With NSCLC
NCT02285361
·
clinicaltrials.gov ↗
COMPLETED
Status
1272
Enrollment
INDUSTRY
Sponsor class
Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG:
GIOTRIF 20mg
DRUG:
GIOTRIF 40mg
DRUG:
GIOTRIF 30mg
Sponsor
Boehringer Ingelheim